Japan to review drug prices annually rather than every 2 years
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Tokyo
THE Japanese government plans to start reviewing drug prices every year, instead of every two years, to try to reduce mounting healthcare costs, government officials with direct knowledge of the decision said on Monday.
The move reflects growing resistance to rising drug prices around the world.
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium